Traws Pharma Inc TRAW Q1 2026 Earnings Narrower Net Loss Beats Estimates as Clinical Pipeline Advances OMC Q1 2026 Earnings EPS Beats Estimates by 179 FPH Q1 2026 Earnings Narrowing Loss Amid Challenging Market Conditions ROST Q1 2026 Earnings Strong EPS Beat Drives Stock Rally VELO Q1 2026 Earnings Strong EPS Beat Shocks Market Revenue Remains Undisclosed INTA Q1 2026 Earnings Narrow EPS Beat Highlights Operational Discipline Amid Market Caution